Neonatal hearing screening

Eur J Pediatr. 1996 Jun;155(6):429-35. doi: 10.1007/BF01955176.

Abstract

Severe congenital hearing impairment is an important handicap affecting 0.1% of live-born infants and 1%-2% of graduates of Neonatal Intensive Care Units. The prognosis for intellectual, emotional, language and speech development in the hearing-impaired child is improved when the diagnosis is made early and intervention is begun before the age of 6 months. The usual age at diagnosis of hearing impairment is at least 18-30 months (or even later in cases of less severe hearing impairment) where there are no screening programmes. When screening is carried out using distraction methods at the age of approximately 9 months some hearing-impaired infants are missed and those discovered are at least 15-18 months before intervention begins. Neonatal screening could give hearing-impaired children the best chances for optimal care and development. Universal neonatal hearing screening is necessary, because, when neonatal hearing screening is restricted to high risk groups 30%-50% of infants with hearing loss are not discovered. The methods available for neonatal hearing screening are discussed in this paper.

Conclusion: In our view automated measurement of auditory brainstem responses is the most valuable method for universal neonatal hearing screening.

Publication types

  • Review

MeSH terms

  • Audiometry, Evoked Response*
  • Brain Stem / physiopathology
  • Cochlear Nerve / physiopathology
  • Deafness / etiology
  • Deafness / physiopathology
  • Deafness / prevention & control*
  • Evoked Potentials, Auditory, Brain Stem / physiology
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Neonatal Screening*
  • Netherlands
  • Otoacoustic Emissions, Spontaneous* / physiology
  • Risk Factors
  • Signal Processing, Computer-Assisted